1. Home
  2. AIMD vs SFHG Comparison

AIMD vs SFHG Comparison

Compare AIMD & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • SFHG
  • Stock Information
  • Founded
  • AIMD 1984
  • SFHG 1993
  • Country
  • AIMD United States
  • SFHG Hong Kong
  • Employees
  • AIMD N/A
  • SFHG N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • AIMD Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • AIMD 16.9M
  • SFHG 14.9M
  • IPO Year
  • AIMD N/A
  • SFHG 2024
  • Fundamental
  • Price
  • AIMD N/A
  • SFHG N/A
  • Analyst Decision
  • AIMD
  • SFHG
  • Analyst Count
  • AIMD 0
  • SFHG 0
  • Target Price
  • AIMD N/A
  • SFHG N/A
  • AVG Volume (30 Days)
  • AIMD 75.2K
  • SFHG 62.3K
  • Earning Date
  • AIMD 11-05-2025
  • SFHG 04-16-2025
  • Dividend Yield
  • AIMD N/A
  • SFHG N/A
  • EPS Growth
  • AIMD N/A
  • SFHG N/A
  • EPS
  • AIMD N/A
  • SFHG N/A
  • Revenue
  • AIMD $110,870.00
  • SFHG $19,760,935.00
  • Revenue This Year
  • AIMD N/A
  • SFHG N/A
  • Revenue Next Year
  • AIMD N/A
  • SFHG N/A
  • P/E Ratio
  • AIMD N/A
  • SFHG N/A
  • Revenue Growth
  • AIMD 70.25
  • SFHG 30.89
  • 52 Week Low
  • AIMD $2.00
  • SFHG $0.55
  • 52 Week High
  • AIMD $5.00
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 61.80
  • SFHG 35.03
  • Support Level
  • AIMD $3.46
  • SFHG $0.64
  • Resistance Level
  • AIMD $3.95
  • SFHG $0.71
  • Average True Range (ATR)
  • AIMD 0.20
  • SFHG 0.04
  • MACD
  • AIMD 0.02
  • SFHG -0.01
  • Stochastic Oscillator
  • AIMD 90.54
  • SFHG 8.87

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: